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ABSTRACT
PROMOTING SELF-EFFICACY AMONG HEAD AND NECK
CANCER PATIENTS
Current survivorship visits at the Stanford head and neck oncology program
are not standardized to address ongoing post-treatment sequelae. The objectives of
this study help to address whether current non-standardized visits actually help to
empower patients to self-manage their chronic diagnosis of head and neck cancer
by measuring their self-efficacy levels before and after their post-treatment
survivorship visit.
Given the convenience sampling method, 17 patients were enrolled in
this quasi-experimental pilot study. Demographic information was collected for
each patient: gender, ethnicity, smoker status, and age. Head and neck cancer
patients would first be surveyed before and after their follow up visit using the
data collection tools: Chronic Illness Management Self-Efficacy Scale or the 6item General Self- efficacy scale. One sided t tests and ANOVA were used for to
compute and examine the statistical significance of improved self-efficacy values.
Current non-standardized survivorship follow- up visits designed with a written
treatment summary have shown to improve self-efficacy levels. Age and smoking
status were found to be statistically significant confounding factors.
Transition survivorship visits should aim to improve self-efficacy levels
among head and neck cancer survivors. American Cancer Society guidelines for
follow up care can guide the conversations of survivorship issues and facilitate
communication between cancer specialists and community providers.
Lily Lam
May 2019
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CHAPTER 1: INTRODUCTION
Background: Cancer as a Chronic Illness
The burden of chronic illness care and management is on the rise in the
United States (Centers for Disease Control and Prevention, 2017). Concurrent
chronic illnesses that may also be linked and affect multiple organ or physiological
systems. Chronic illness is filled with uncertainty as the predictability of outcomes
is heavily influenced by self-management, access to healthcare, resources in the
community, and care coordination. Chronic illness is responsible for variable and
constant disruptions from going about and proceeding with normal daily activities.
Management of chronic illnesses is reliant on the understanding of the diagnoses,
coping with the conditions, handling day to day disruptions, and coming to terms
with living with their diagnosis.
Healthcare in the United States is heavily weighted as acute care
management and short-term disease management rather than chronic illness
prevention. With this focus on acute care management, the burden of chronic
illness management increases. Current healthcare systems lack processes and
instruments for chronic illness management, which is often difficult to implement
during an acute care episode. Given the complexities involved in chronic illness
management, it requires a delivery system that is comprehensive and inconclusive
of community resources. It needs to be encouraging of self-management and
promoting healthy behaviors across the lifespan for optimal outcomes. Shifting
health care from acute focused and episodic care focus to promote preventative
healthcare and healthy behaviors across the lifespan is essential to address the
increasing needs of those who are chronically ill.
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Cancer is defined as a chronic illness (Hebdon, Foli, & McComb, 2015).
The transition from active treatment for the cancer patient to survivorship can be a
period of uncertainty for the patient and their families. This is due to the
“ambiguity of their illness state, treatment complexity, information gaps, and
unpredictable disease course” (Hebdon et al., 2015, p.1776). The undertreated and
overlooked survivorships issues specifically for head and neck cancer patients
need to be addressed to promote overall positive outcomes. Multiple psychosocial,
and physical sequela from active treatment is known and predictable.
Survivorship includes issues related to the ability to get healthcare and follow-up
treatment, late effects of treatment, second primary cancers, and quality of life
(Simcock & Simo, 2016). Other survivorship issues include: dental care, trismus,
hypothyroidism, swallowing, xerostomia, second cancers, smoking and alcohol,
vascular injury, ototoxicity, financial, depression, and quality of life (Simcock &
Simo, 2016). Multiple providers can share the responsibilities of managing the
patients with head and neck cancer, which may increase the opportunity for
conflicting information for the management of their chronic conditions. This can
result in unnecessary duplication of imaging or other diagnostic tests, driving up
the costs of healthcare, and become frustrating for the patient. As five-year
survival rates continue to rise due to improvements in cancer treatment protocols
and continued evidence-based practice, the number of head and neck cancer
survivors needing to be managed increase.
The transition from active treatment to maintaining stability and living with
the chronic illness can only happen by empowering the patient, maintaining
patient-provider relationships, and continued adjustment and flexibility in
management for each individual patient. The Institute of Medicine has highlighted
the importance of addressing cancer survivorship issues for long term
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improvement of health outcomes. One of the simple mechanisms recommended to
improve quality of life of a cancer survivor is the implementation of completed
cancer treatment plans in follow up visits for a cancer survivor and ongoing plan
for continued surveillance (Committee on Cancer Survivorship, 2006). An
effective survivorship care visit and transition plan can help with the uncertainty
of cancer as a chronic illness during the transition to routine follow up. Inability to
create appropriate treatment plans and continued management can lead to
fragmented and gaps in care, ultimately resulting in poor outcomes.
Theoretical Framework
Bandura’s (1982) exploration of self-efficacy beliefs as an element of the
social cognitive theory help describes a person’s willingness and motivations to be
able to make the outcomes, they want by the actions they take. The self-efficacy
beliefs can also be used to explain how an individual can respond to the
unexpected adversary or stressful events in their lives; it can be used to describe
their outlook on the outcomes of a situation and the choices that may make as a
response. Self-efficacy beliefs can influence the course of actions a person may
take, usually completed tasks reflect competence and confidence. Self-efficacy
beliefs are formed when a person engages in activities and actions that are then
interpreted to be either beneficial or missteps. They begin to develop an idea or
belief that they are capable of continuing the course of action that would be
interpreted as valuable. In fact, the beliefs of self-efficacy have been used to guide
and frame the development of chronic diseases management.
Cancer as a chronic illness requires management over a longer period of
time. A patient’s health beliefs and self- efficacy can play a large role in the
successful management of the psychological and physical tolls of cancer. Self-
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efficacy in this regard is the theorized level of confidence a patient or their
caregiver may have in managing some of the psychological and physical sequelae
of active cancer treatment. Patients with measured higher levels of self-efficacy
tend to be able to better self-manage their chronic illnesses (Foster et al., 2015,
p.11). These patients are more self-aware of the care needed to continue moving
forward and actively participate in the decision-making process in addressing the
sequela of cancer treatment. Patients who are able to successful self-manage make
decisions to enhance and maintain their quality of life, ultimately leading to better
health outcomes. Patients who have higher levels of self-efficacy have higher
levels of belief that they can alter and change their health behavior in order to
promote certain outcomes.
Aim of Study
Prior cancer survivorship studies show a clear absence of succinct
transitions of care for head and neck cancer patients after cancer treatment which
impact their quality of life and health outcomes. The Institute of Medicine has
highlighted the importance of addressing cancer survivorship issues for long-term
improvement of health outcomes. Hypothesized mechanisms to increase overall
survival and improved quality of life for surviving head and neck cancer patients
is to empower them with the knowledge of their completed treatment plan, and to
provide written expectations of follow up care in order to address issues of
survivorship: acute and long-term late effects of treatment, prevention of
secondary cancers, cancer surveillance for recurrence, and coordination of care.
National cancer guidelines for ongoing management frame the recommendations
for follow up care in cancer care as patients enter into a period of watchful
waiting. Cancer as a chronic illness requires management over a longer period of
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time. A patient’s health beliefs and self-efficacy can play a large role in the
successful management of the psychological and physical tolls of cancer. Selfefficacy in this regard is the theorized level of confidence a patient or their
caregiver may have in managing some of the psychological and physical sequelae
of active cancer treatment.
Current survivorship visits at the Stanford head and neck oncology program
are not standardized to address ongoing post-treatment sequalae. The lack of a
standard survivorship care plan allows for the flexibility of information delivered
and is consequently reliant on the knowledge base of the head and neck oncologist
determining what information is vital. Patients are given access to electronic chart
notes that highlight a treatment summary and a written follow up care plan
designed by their oncologist. Survivorship templates are being created by the
American Society of Clinical Oncology to highlight key elements that should be
included in care plan components such as treatment summary and follow up
recommendations but are not utilized in the Stanford head and neck oncology care
program. The aims of this research will help to answer if non-standardized current
survivorship visits with written treatment summary and plan for head and neck
cancer patients currently help to improve self-efficacy to enhance selfmanagement of acute and long-term effects of their cancer treatments. The
objectives of this study help to address whether current non-standardized visits
actually help to empower patients to self-manage their chronic diagnosis of head
and neck cancer by measuring their self-efficacy levels before and after their posttreatment survivorship visit.
The hypothesis was made that currently head and neck cancer patients
treated in the Stanford head and neck oncology program do not exhibit higher
levels of self-efficacy in the current non-standardized survivorship visit.

DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638

CHAPTER 2: LITERATURE REVIEW
Gaps in Literature
A literature review of head and neck cancer survivorship transitions and
existing use of survivorship care plans revealed a number of qualitative or
descriptive studies available discussing the need of a survivorship care plan among
this population in order to improve quality of life issues. CINAHL database was
used to search for squamous cell carcinoma of head and neck, resulted in 13
articles. A second search using the CINAHL database for key terms, cancer
survivorship, and self-efficacy resulted in 20 articles. A third search for
survivorship care plans resulted in 321 articles. Not all articles were related to
head and neck cancer survivorship. There were limited articles, but what was
noted to be true was that self-advocacy and self-efficacy are contributing factors to
better health outcomes in the cancer survivor population. Given the gaps in the
literature addressing the head and neck cancer population, it is pertinent to
investigate if survivorship transition visits with written treatment summaries and
follow up plan will improve self-efficacy and empowerment for head and neck
cancer patients in the management of acute and long-term effects of cancer
treatment. The articles presented in this literature review do not discuss in detail
all articles related to head and neck cancer survivorship but are most pertinent for
this study.
A literature review of current survivorship transition tools for head and
neck cancer patients highlights the lack of a standard tool that had measurable
outcomes for increasing a HNC patient's quality of life and confidence in selfmanagement of their chronic illness. Several qualitative studies of cancer
survivors address the need and importance of having a written treatment summary
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as well as a follow-up plan in order to improve quality of life outcomes. There
were no studies measuring head and neck cancer patient confidence in advocating
for their continued health issues. The studies that are available do not address the
very distinct head and neck population in Northern California. This study aims to
address how the survivorship visits with written treatment plans and summaries
affect self-efficacy among specifically head and neck cancer survivors.
Previous Literature
The previous prospective and observation outcomes study by authors Funk,
Karnell and Christensen (2012) examined health related quality of life (HRQOL)
among 5-year head and neck cancer survivors. They wanted to examine the longterm impact of HRQOL among head and neck cancer survivors. By identifying
specific characteristics of this patient population, the authors were hoping to be
able to predict and determine HRQOL among specific patients. This study used
univariate analysis and multivariate regression analysis to review their data. This
particular analysis method was crucial in being able to find relationships between
head and neck cancer patient characteristics and HRQOL outcomes. The
conclusions drawn from the statistical analysis looking at HNC long-term health
outcomes were used to describe how important it is for future research to improve
interventions to improve health outcomes in the various categories of eating,
speech, aesthetics, social disruptions, physical health, mental health, and overall
quality of life. The limitations of this study did not examine several other factors
that could contribute to also worse quality of life outcomes such as socioeconomic
factors, insurance, health literacy, or social support networks as well. Despite quite
a large sample population in a long-term study, the sample population was drawn
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from one geographic area and institution. The results of this study may not
necessarily be generalizable to all HNC patients at other institutions.
In a smaller qualitative study conducted by the authors Nund, Ward,
Scarinci, Cartmill, Kuipers, and Porceddu in 2014, head and neck cancer patients
were interviewed to collect information from the patient perspective on speech and
swallowing issues and access to services. Open ended interviews were conducted,
and statements were coded into categories where participants shared similar
comments. Key themes were identified in the survivorship periods to use in
futures studies for exploration. Conclusions drawn from these themes and
interviews had significant implications on clinical practice. The authors were able
to give clear suggestions of future research and design of interventions in order to
address what is patient perceived issues of speech and swallowing following
cancer treatment and as well as healthcare practitioner access in managing these
issues. This study looks at specifically one post-treatment sequelae head and neck
cancer patients face during the management of their chronic diagnosis. This study
did however account for a patient’s perspective on post-treatment issues which is
essential in modifying healthy behaviors and increasing compliance. Further
studies would need to be conducted in order to address many other post-treatment
sequelae as well.
Kenzik et al. (2016) study looks at specifically the relationship between
treatment summaries with self-efficacy and healthcare use for cancer survivors.
This was a cross-sectional quantitative study conducted among 12 various
hospitals across five states of which all cancer patients were eligible as long as
they would be able to participate in this study. The authors used the Stanford
Chronic Illness Self-Efficacy scale as well as collected demographics and clinical
information to assess for covariance. Three multiple linear regression analysis
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were used for categorical and continuous variables. The strengths of this study
were the large sample size of cancer patients was considered in this study at 12
different institutions spread across five different states. This was a quantitative
study that provided information on the external validity of how transitions impact
care and health outcomes. The authors of the study were able to find positive
associations between verbal explanations of follow up care plans to improve selfefficacy which then provides a foundation for the hypothesis of how survivor selfefficacy could impact decreased emergency room visits and hospitalizations. The
limitations of the study as indicated by the authors were of the reliance of patients
to self-report receiving any of the models of care including treatment summaries,
written follow up care information and verbal follow up care plans. Other
limitations of this study were that it only identified quite a heterogeneous
population of cancer survivors (mainly breast and prostate cancers) and those over
the age of 65. This particular study does not focus on the very specific head and
neck cancer population who has different and varying post-treatment physical and
psychosocial sequelae than the other cancer populations.
When looking at the relationship between the post-treatment experiences of
oral cavity and oropharyngeal cancer survivors, the authors Manne et al. (2016)
conducted a cross-sectional study to help identify continuing needs of the oral
cavity and oropharyngeal cancer survivors. These authors similar to the previous
study were looking at using patient demographics and characteristics to identify
any association with support and information needs. Combined data analysis was
used in this studying including, t-tests for evaluating continuous variables and
stepwise regression for demographic medical and psychological variables.
Bivariate associations were evaluated between background variables and total
information and psychosocial support needs. The authors were able to identify a
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comprehensive set of priority needs in this specific cancer survivor population.
Patients were found to have majority of their ongoing management care by their
oncologist rather than their primary care provider. It is important for healthcare
providers to realize that cancer patients would like more information regarding
late and long-term effects of their treatment. This study highlights a specific head
and neck cancer subset among head and neck cancer survivors in one geographic
location. The authors highlight the need for written treatment summaries and the
discussion regarding acute and late effects of treatment. The authors of this study
do not discuss the levels of self-efficacy as an indicator of confidence levels
needed to manage their ongoing issues in the survivorship period.
Building on previous studies, the authors Mayer et al. (2016) conducted a
pilot randomized controlled study to compare the effectiveness of a survivorship
care plan (SCP) transition visit with a SCP transition visit in addition to a
coordinated follow up visit with the patient’s primary care physician (Mayer et al.,
2016). The authors conducted this study at the REX Cancer hospital, a community
cancer center in Raleigh, North Carolina. 34 adult cancer patients were enrolled in
this study; they were randomized to two arms: survivorship care plan visit with
coordinated follow up with primary care providers or survivorship care plan visits
only. The authors were answering the question on the patient confidence in
survivorship information, the expectations for cancer survivorship care and
satisfaction with care. The authors were also measuring the feasibility of the
intervention as well. Descriptive statistics were used as well as Wilcoxon rank
sum tests for data analysis. Mayer, et al. were able to draw conclusions that it was
indeed feasible to conduct this intervention in a larger population or even more
specific cancer survivor population in order to learn more information about the
impact of survivorship care plan visits. Patients had increased worry with the
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receipt of a survivorship care plan, but those levels of worry decreased when these
patients have a follow up visit with their primary care providers. This particular
study was relatively small for a randomized control trial and did not clearly state
which type of cancer patients they were studying. The results of a survivorship
care plan’s impact on different cancer survivors are also variable in that each
cancer patient population has unique needs.
Self-efficacy is a widely used theory to describe how a person’s confidence
and beliefs frame the actions they take to create solutions to problems they face. In
the application of this social cognitive theory to patients with chronic illnesses,
self-efficacy beliefs have a major influence on how motivated patients are in
complying with a treatment plan. A literature review of the current survivorship
care dedicated for head and neck cancer patients show that there is a gap of studies
highlighting how best to improve survivorship for head and neck patient
population by addressing self-efficacy. Some of the current studies available for
review have been conducted to look at the health-related outcomes in terms of
survivorship care planning for all cancer patient populations and generalizations
from these studies cannot be applied to the very specific head and neck cancer
population. There were no specific studies looking at the relationship between
self-efficacy and head and neck cancer survivorship issues. Bandura’s theory of
self-efficacy helps frame this study to address the gap in literature looking at how
confident a head and neck cancer patient is in addressing ongoing post-treatment
issues via a guided survivorship transition visit with their healthcare practitioner.
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CHAPTER 3: METHODOLOGY
Design and Sample
The sampling method for this quasi-experimental study was of
convenience. The idea of a transition tool and standardized head and neck
survivorship clinic visit is still being established at Stanford. A simple random
sampling in which patients who fit the inclusion criteria would be randomly
selected to be surveyed would be ideal. However, in order to get a larger number
of patients to participate, convenience sampling was most feasible. Given the
convenience sampling method, 17 patients were enrolled in the study. Subjects
were enrolled during October 2018 - January 2019 for data collection and
screening. Demographic information was collected for each patient: gender,
ethnicity, smoker status, and age (either above 65 or younger than 65). Analysis of
participants' surveys were conducted from January -February 2019. The study took
place at the Stanford outpatient head and neck oncology clinic. Stanford
Hospital/Cancer Center IRB approval was obtained in order to enroll patients in
this population. The visits were conducted by nurse practitioners and physicians.
The total time of recruitment and survey conducted was approximately 10-15
minutes.
Participants
Head and neck cancer patients who have received at least two treatment
modalities for head and neck cancer were eligible for participation as long as they
received at least one modality of treatment at Stanford within the last five years.
The sample population differs from other samples of other researchers in the
literature review given the diversity of the HNC population at Stanford, a large
academic tertiary center for care. Patients are coming from various socio-
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economic backgrounds; confounding factors that could contribute to improving
self-efficacy were considered. Patients who cannot read or understand English
were excluded from this study; they can be evaluated at a later phase of the
clinical trial. Head and neck cancer patients screened were able to read the waiver
of authorization for consent. They needed to be able to verbalize their consent for
the study. Patients who were enrolled to participate in this study were scheduled
for a survivorship visit. The providers (NPs/PAs/MDs) reviewed their patients’
chart at the time that they are seeing the patient in clinic via EPIC (electronic
medical record system) and asked their patient if they were willing volunteer to
participate in the study if they met eligibility criteria.
The general sample population consisted of 17 patients. Eight patients were
older than 65, and nine patients were younger than 65. There were five females
and twelve males that completed the survey. There were two Asians, thirteen
Caucasians, and two Hispanics enrolled in the study. There were thirteen nonsmokers and four former smokers in the survey.
Tools for Measurement
During the visit, the patients would first be surveyed using the data
collection tool: Chronic Illness Management Self-Efficacy Scale or the 6-item
General Self- efficacy scale. As part of the visit, HNC patients will be given a
written treatment summary and continued plan of treatment (transition tool
intervention) for standard care. Following the visit, participants will then be again
surveyed using the data tools. The scales/tools are available for use by an
individual without permission given funding from the National Institute of
Nursing Research. There are easily downloaded from the Self-Management
Resource Center website.
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Instrument 1. The Stanford Chronic Illness Management Self-Efficacy
Scale (SCIMSS) was used as a pre-and post-intervention survey for data
collection. The original scale has various survey questions about the confidence of
patients in several areas in a range of 1-10, 10 being totally confident. The areas of
CIMSES that are specifically addressing self-efficacy and confidence in selfmanagement of cancer as a chronic illness include: getting information about the
disease, obtaining help from community, family, friends scale, communicating
with physician scale, managing disease in general scale, and managing of
symptoms scale. The tool has been normed on a range of a number of participants,
292-478 and have a internal consistency reliability of .77 - .92 with a test and
retest reliability of .72-.89.
Instrument 2. The short form 6-item GSE (General Self-Efficacy Scale)
created by Schwarzer and Jerusalem (1995) which has a Cronbach's alpha between
.79 and .88 was also used for data collection. This instrument has been validated
and used in assessing self-efficacy in chronic illness management. This scale was
tested on 605 patients with chronic disease and has an internal consistency
reliability score of .91.
Data analysis
Descriptive statistical analyses were performed on the sample groups to
obtain a clear understanding of the population. One sided t tests and ANOVA were
used for to compute and examine whether the follow up survivorship visits
improve self-efficacy values for the head and neck patient population.

DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638

CHAPTER 4: RESULTS AND DISCUSSION
Self-Efficacy Changes
For the six SCIMSS questions and the ten GSE questions, statistical tests
were performed to see if the mean responses are statistically improved for the
post- versus the pre-survivorship visits scores by the patients. These are one-sided
tests because we assume that the mean post responses are either greater than the
pre-responses or equal.
Table 1 summarizes the results for the SCIMSS questions. For each
question, the mean score (averaged over the seventeen responses) is listed along
with the standard deviation. The t statistic for testing if the population mean
difference is greater than zero is then displayed. The p value is the level of
significance which transfers the t statistic based on a one-tailed test with 16
degrees of freedom. The same analysis is done for the average of the six GSE
questions, which is in the last row.
A p value below 0.05 is considered to be statistically significant implying
higher scores after counseling than before counseling. Question SCIMSS -1 was
found to be statistically significant. SCIMSS -1 asks how confident patients feel
they can manage their fatigue from interfering with the things they do. The
average of patients’ confidence levels has improved when asked about managing
their fatigue. Patients do not show an overall improvement in self-efficacy with
the current scheduled survivorship visit with written treatment plan via the
SCIMSS scale. Given that there is no statistical significance in the average pre and
post- visit self-efficacy levels as captured in the surveys, the hypothesis remains
correct, patient’s do not report increased self-efficacy with the current
survivorship transitional follow up visit using the SCIMSS scale.
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Table 2 contains the same analysis for the GSE questions. Questions GSE2 and GSE-9 were found to be statistically significant. The average for all ten
GSE questions was also found to be statistically significant. Using the GSE scale,
patients do report levels of higher self-efficacy following the survivorship
transition visit. The hypothesis is proven to not be true, self-efficacy levels
increase with the current survivorship visits with written treatment plans using the
GSE Scale.
Table 1
SCIMSS (Post -Pre)
St.
Questions

Mean

Dev.

t

p

SCIMSS-1

0.235

0.437

2.22

0.021

SCIMSS-2

0.176

0.529

1.38

0.094

SCIMSS-3

-0.176

0.809

-0.90

0.809

SCIMSS-4

0.059

0.429

0.57

0.290

SCIMSS-5

0.059

0.748

0.32

0.375

SCIMSS-6
SCIMSSAverage

-0.059

0.243

-1.00

0.834

0.049

0.275

0.74

0.236

Note. SCIMSS-1(in bold) is statistically significant (p <0.05).
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Table 2
GSE (Post-Pre)
Questions

Mean

St. Dev.

t

p

GSE-1

0.059

0.429

0.57

0.290

GSE-2

0.176

0.393

1.85

0.041

GSE-3

0.000

0.000

-------

-------

GSE-4

0.000

0.500

0.00

0.500

GSE-5

-0.059

0.243

-1.00

0.834

GSE-6

0.059

0.243

1.00

0.166

GSE-7

0.000

0.000

-------

-------

GSE-8

0.059

0.243

1.00

0.166

GSE-9

0.235

0.437

2.22

0.021

GSE-10

0.059

0.429

0.57

0.290

GSE-Average
0.059
0.087
2.79
0.007
Note. GSE-2, GSE-9, and GSE-Average highlighted in bold is statistically
significant (p <0.05)
Demographic Effects
Age
Demographic factors were examined to look at the effect made on any
improvements in self-efficacy. The first factor analyzed was age. The age of the
seventeen patients is partitioned into two groups. The first group consists of eight
patients who are older than 65. The second group consists of nine patients who
are younger than 65.
In Table 3, for each of the six SCIMSS questions as well as the averages
over the six questions, the means for the two age groups are listed, as well as the
respective standard deviations. The next column is the t statistic for testing the
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null hypothesis that the population means for the two groups are equal, against the
alternative hypothesis that the two population means differ. The p value (also
known as the level of significance) is based on the t distribution with 15 degrees of
freedom. A p value below 0.05 is considered to be statistically significant. None
of the SCIMSS responses are determined to be affected by the age factor. Age was
not a confounding factor when looking at increased self-efficacy levels following
a survivorship visit using the SCIMSS scale.
Table 4 consists of the same analysis for the GSE questions. On question
GSE-9, the older patients tended to record statistically greater improvements than
the younger patients. That specific question is bolded. Age was a confounding
factor in improved self-efficacy levels following a transitional survivorship visit
for patients older than 65 using the GSE scale. Patients who are younger than 65
do not have a reported increase in self-efficacy level following their survivorship
visit.
Conclusions can be made that age influences reports of self-efficacy levels
if we consider the statistical significance of the averages on pre and post-test were
unchanged on SCIMSS and higher on the GSE survey.
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Table 3
SCIMSS (Age)
Mean

St. Dev.
t

p

Questions

Older

Younger

Older

Younger

SCIMSS-1

0.250

0.222

0.463

0.441

0.13

0.901

SCIMSS-2

0.000

0.333

0.000

0.707

-1.33

0.203

SCIMSS-3

-0.125

-0.222

0.354

1.093

0.24

0.813

SCIMSS-4

0.000

0.111

0.000

0.601

-0.52

0.609

SCIMSS-5

-0.125

0.222

0.835

0.667

-0.95

0.355

SCIMSS-6

0.000

-0.111

0.000

0.333

0.94

0.362

SCIMSS-Average

0.000

0.093

0.236

0.313

-0.68

0.505

t

p

Table 4
GSE (Age)
Mean

St. Dev.

Questions

Older

Younger

Older

Younger

GSE-1

0.125

0.000

0.354

0.500

0.59

0.565

GSE-2

0.000

0.333

0.000

0.500

-1.88

0.079

GSE-3

0.000

0.000

0.000

0.000

-------

-------

GSE-4

0.000

0.000

0.535

0.500

0.00

1.000

GSE-5

-0.125

0.000

0.354

0.000

-1.07

0.303

GSE-6

0.000

0.111

0.000

0.333

-0.94

0.362

GSE-7

0.000

0.000

0.000

0.000

-------

-------

GSE-8

0.000

0.111

0.000

0.333

-0.94

0.362

GSE-9

0.500

0.000

0.535

0.000

2.82

0.012

GSE-10

0.125

0.000

0.354

0.500

0.59

0.565

GSE-Average

0.063

0.056

0.074

0.101

0.16

0.876

DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638

20
Note. GSE-9 highlighted in bold is statistically significant (p <0.05).

Gender
Gender was compared as a factor in affecting the responses. There were
five females and twelve males in the survey. In Table 5, the means for both
genders are listed along with the pooled standard deviation. The t test statistic is
listed with the corresponding p value. The p value is based on the t distribution
with 15 degrees of freedom. On none of the SCIMSS questions was gender found
to be a statistically significant factor in affecting the differences. The same is true
for the SCIMSS averages. The same analysis was done for the GSE questions in
Table 6. No statistically significant effects due to gender were found. Gender did
not play a role in improved self-efficacy levels following a survivorship visit with
written treatment summary.
Table 5
Self-Efficacy (Gender)
Mean

St. Dev.

t

p

0.452

-0.21

0.838

0.000

0.622

-0.88

0.391

-0.167

0.447

0.937

-0.07

0.941

0.000

0.083

0.000

0.515

-0.36

0.727

SCIMSS-5

-0.400

0.250

0.894

0.622

-1.73

0.102

SCIMSS-6

0.000

-0.083

0.000

0.289

0.63

0.535

SCIMSS-Average

-0.067

0.097

0.253

0.279

-1.13

0.275

Questions

Female

Male

Female

Male

SCIMSS-1

0.200

0.250

0.447

SCIMSS-2

0.000

0.250

SCIMSS-3

-0.200

SCIMSS-4
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Table 6
GSE (Gender)
Mean

St. Dev.

t

p

0.515

-0.36

0.727

0.000

0.452

-1.21

0.243

0.000

0.000

0.000

-------

-------

0.200

-0.083

0.447

0.515

1.07

0.301

GSE-5

-0.200

0.000

0.447

0.000

-1.63

0.123

GSE-6

0.000

0.083

0.000

0.289

-0.63

0.535

GSE-7

0.000

0.000

0.000

0.000

-------

-------

GSE-8

0.000

0.083

0.000

0.289

-0.63

0.535

GSE-9

0.200

0.250

0.447

0.452

-0.21

0.838

GSE-10

0.000

0.083

0.000

0.515

-0.36

0.727

GSE-Average

0.020

0.075

0.045

0.097

-1.20

0.246

Questions

Female

Male

Female

Male

GSE-1

0.000

0.083

0.000

GSE-2

0.000

0.250

GSE-3

0.000

GSE-4

Smoking Status
The effect of non-smokers and former smokers were also examined. There
were thirteen non-smokers and four former smokers in the survey. Using a similar
analysis to that done for age and gender, we find that question SCIMSS-4 was
statistically different in that former smokers had a larger improvement. All the
SCIMSS questions showed larger improvements for former smokers, although
SCIMSS-4 was the only one which was found to be statistically significant.
SCIMSS -4 looked at how confident a patient feels that they can keep other
symptoms or health problems from interfering with things they want to do. For
patients who were former smokers, following their survivorship follow-up visit,
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they have increased confidence in managing their other symptoms and health
problems. The overall SCIMSS average was also determined to be statistically
significant. This offers insight that patients who are former smokers do report
higher levels of self-efficacy after their survivorship follow up visits; therefore,
visits can be amended to highlight this specific subset of head and neck cancer
patients.
For the GSE questions, only GSE-2 was found to be statistically significant
with former smokers having a larger improvement. Question 2 of the GSE survey
measures how true a patient feels that they can find a way and means to get what
they want if someone opposes them. Following a survivorship visit, former
smokers show improved confidence levels; they appear to feel more empowered in
discussing what they need from someone else.
Table 7
Self-Efficacy (Smoker)
Mean

St. Dev.
Former

Questions

Non-Smoker Smoker

Non-

Former

Smoker

Smoker

t

p

SCIMSS-1

0.154

0.500

0.376

0.577

-1.53

0.144

SCIMSS-2

0.154

0.250

0.555

0.500

-0.33

0.744

SCIMSS-3

-0.308

0.250

0.855

0.500

-1.32

0.207

SCIMSS-4

-0.077

0.500

0.277

0.577

-3.03

0.008

SCIMSS-5

-0.077

0.500

0.641

1.000

-1.49

0.155

SCIMSS-6
SCIMSSAverage

-0.077

0.000

0.277

0.000

-0.58

0.568

-0.038

0.333

0.227

0.236

-3.05

0.008

Note. SCIMSS-4 highlighted in bold is statistically significant (p <0.05).
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Table 8
GSE (Smoker)
Mean

St. Dev.
t

p

0.816

0.33

0.748

0.277

0.577

-2.22

0.041

0.000

0.000

0.000

-------

-------

0.000

0.000

0.577

0.000

0.00

1.000

GSE-5

-0.077

0.000

0.277

0.000

-0.58

0.568

GSE-6

0.077

0.000

0.277

0.000

0.58

0.568

GSE-7

0.000

0.000

0.000

0.000

-------

-------

GSE-8

0.000

0.250

0.000

0.500

-2.10

0.052

GSE-9

0.308

0.000

0.480

0.000

1.35

0.197

GSE-10

0.077

0.000

0.494

0.000

0.33

0.748

0.054

0.075

0.088

0.096

-0.44

0.663

Non-

Former

Smoker

Smoker

Non-Smoker

Smoker

GSE-1

0.077

0.000

0.277

GSE-2

0.077

0.500

GSE-3

0.000

GSE-4

Questions

Former

GSEAverage

Note. GSE-2 highlighted in bold is statistically significant (p <0.05).
Ethnicity
For ethnicity, there were three ethnic groups represented in the sample.
There were two Asians, thirteen Caucasians, and two Hispanics. For each
question, Tables 9 and 10 show the means for the three ethnic groups along with
the pooled standard deviation. The statistical test that the three ethnic population
means are equal is the analysis of variance (ANOVA). The test statistic is an F.
The p value is obtained from the F distribution with 2 and 14 degrees of freedom.
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None of the SCIMSS or GSE questions were statistically significant. Ethnicity was
not a factor that played a contributing role in affecting the levels of self-efficacy
following a follow up visit.
Table 9
SCIMSS (Ethnicity)
Mean

St. Dev.

F

p

0.000

0.445

0.732

0.498

0.231

0.000

0.555

0.264

0.771

0.000

-0.231

0.000

0.858

0.111

0.896

SCIMSS-4

0.000

0.077

0.000

0.457

0.043

0.958

SCIMSS-5

0.000

0.077

0.000

0.798

0.014

0.986

SCIMSS-6

0.000

0.077

0.000

0.257

0.137

0.873

SCIMSS-Average

0.000

0.064

0.000

0.292

0.074

0.929

Questions

Asian

Caucasian Hispanic

SCIMSS-1

0.000

0.308

SCIMSS-2

0.000

SCIMSS-3
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Table 10
GSE (Ethnicity)
Mean

St. Dev.

F

p

0.000

0.457

0.043

0.958

0.231

0.000

0.406

0.494

0.620

0.000

0.000

0.000

0.000

-------

-------

GSE-4

0.000

-0.077

0.500

0.494

0.043

0.956

GSE-5

0.000

-0.077

0.000

0.257

0.137

0.873

GSE-6

0.000

0.077

0.000

0.257

0.137

0.873

GSE-7

0.000

0.000

0.000

0.000

-------

-------

GSE-8

0.000

0.308

0.000

0.445

0.137

0.873

GSE-9

0.000

0.308

0.000

0.445

0.732

0.498

GSE-10

0.000

-0.077

0.000

0.257

0.137

0.873

GSE-Average

0.000

0.069

0.050

0.090

0.527

0.601

Questions

Asian

Caucasian Hispanic

GSE-1

0.000

0.077

GSE-2

0.000

GSE-3

This study demonstrates that current survivorship follow- up visits designed
with a written treatment summary have shown to improve self-efficacy levels
among head and neck cancer patient survivors. Further analysis looking at the
effect of several demographics such as age, gender, smoking status and ethnicity,
showed that patients older than 65 had increased levels of self-efficacy (increased
confidence in their ability to make decisions and manage their own care) as well as
those who were former smokers. Ethnicity and gender had no increased selfefficacy levels following their scheduled survivorship follow up visits.
It is important to remember that Bandura’s theory of self-efficacy when
looking at the results of this study. A patient’s self-efficacy level is their
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willingness and motivations to be able to make the outcomes they want and have
the confidence to take the actions they need to complete. Previous survivorship
studies have shown that patients feel more confident that they can make the
necessary decisions in their own healthcare choices when they receive adequate
information about their previous treatment and expectations of what is to come in
the future. This study shows that current survivorship visits at Stanford outpatient
clinics for the head and neck cancer population do provide the necessary
information to improve self-efficacy levels.
Summary
Seventeen Stanford head and neck cancer patients were given
questionnaires prior to and after their routine schedule survivorship follow up
visit. The survey consisted of two sets of self-evaluation questions. There were
six questions in the Self-Efficacy for Managing Chronic Disease (SCIMSS)
category and ten questions in the General Self-Efficacy (GSE) category. The
responses were scored ranging from one to four.
An analysis was performed on each of the questions to statistically test if
the population mean scores improved before and after their survivorship transition
visit with written treatment summary. The analysis was also performed on the
averages for the two categories. Demographics were also tested to see how they
factored into an effect on the improvement of self-efficacy scores.
Demographics such as age, gender, ethnicity, and smoking status were also
looked at to see if these factors had a role in impacting reported self-efficacy
levels. For demographics, we find that age had a statistically significant effect on
question GSE-9 with older patients tending to have a greater improvement.
Gender had no effect on improved scores. Former smokers had a statistically
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greater improvement for questions SCIMSS-4 and GSE-2 as well as the average
SCIMSS score compared to non-smokers. Ethnicity had no effect.
Questions SCIMSS-1 and GSE-2 were found to have statistically
significant improvements at the 5% significance level. The mean average
improvement for GSE was also determined to be statistically significant.
Therefore, the hypothesis was proven to be incorrect; current survivorship visits
have found to be statistically significant in improving self-efficacy of the head and
neck cancer survivors.
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CHAPTER 5: CONCLUSION
The aim of this study was to evaluate how the current survivorship visits at
Stanford head and neck oncology clinic improve self-efficacy levels of the head
and neck cancer survivors. The results of the study support the current nonstandardized survivorship follow up visits to improve self-efficacy levels for the
head and neck survivor. Healthcare practitioners who completed these
survivorships follow up visits with written treatment plans and follow up care
incorporate recommended follow up guidelines for the head and neck cancer
survivor.
This study can serve as a pilot study for the Stanford head and neck cancer
program; it contains a small number of participants. A larger number of
participants can be recruited when further evaluation of a standardized
survivorship follow-up visit is conducted. This study was conducted in a short
duration of time but can be expanded in future studies for repeat measurements on
levels of self-efficacy. An area of potential study could examine how serial
survivorship follow ups impact the levels of self-efficacy of head and neck cancer
survivors. Additional studies can be completed based on this study result to look at
the levels of self-efficacy change from diagnosis, throughout treatment and
subsequently after head and neck cancer treatment.
The results of this study aim to answer the Healthy People 2020 initiative to
increase the proportion of cancer survivors who are living 5 years or longer after
diagnosis (U.S. Dept of Health and Human Services [HHS], 2018). The 2005 IOM
report has made several recommendations in terms of survivorship care; it
recognized that the quality of care after cancer treatment is lacking and this can
contribute to a lower number of cancer survivors living more than 5 years after
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diagnosis. There is a gap in the coordination of care between specialists and
generalists. This can drastically impact the quality of care and unique needs of
patient issues after active cancer treatment.
Mechanisms to ensure increase overall survival and improved quality of life
for surviving head and neck cancer patients is to empower them with the
knowledge of their completed treatment plan and provide the expectations of
follow up care in order to address issues of survivorship. Transition survivorship
visits should aim to improve self-efficacy levels among head and neck cancer
survivors. American Cancer Society guidelines and recommendations for follow
up care can guide the conversations of survivorship issues and facilitate
communication between cancer specialists and community providers such as the
primary care physicians. Healthcare professionals and head and neck cancer
programs need to consider ways to promote higher self-efficacy levels when
designing their standardized follow up visits.
Advanced Practice Providers are at the forefront in leading oncology
survivorship. Advanced nursing healthcare practitioners have a large role in
improving the multi-disciplinary care of our cancer survivors. Unclear
expectations of the primary care providers in the long-term management of cancer
survivors creates a gap in practitioners available to provide this essential patient
care service. Advanced practice nurses with advanced training in oncology are
ideal healthcare practitioners who can bridge the gap between the oncology team
and the primary care team to provide optimal care for cancer survivors. They can
enhance communication between the various providers, help to implement cancer
survivorship guidelines, as well as manage acute and chronic post-treatment
sequelae for the cancer survivor in order to ensure there are higher number of
cancer survivors at 5-year survival.
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APPENDIX A: SELF-EFFICACY FOR MANGING CHRONIC
DISEASE 6-ITEM SCALE
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APPENDIX B: GENERAL SELF-EFFICACY SCALE
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